Clinical observation on safety and efficacy of a plasma- and albumin-free recombinant factor VIII for on-demand treatment of Chinese patients with haemophilia A.
about
Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.Octocog alfa, antihaemophilic factor (recombinant), plasma/albumin free method (Advate®): a review of its use in the management of patients with haemophilia A.Meeting the challenges of haemophilia care and patient support in China and Brazil.Octocog alfa (Advate®): a guide to its use in hemophilia A.
P2860
Clinical observation on safety and efficacy of a plasma- and albumin-free recombinant factor VIII for on-demand treatment of Chinese patients with haemophilia A.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinical observation on safety ...... e patients with haemophilia A.
@en
Clinical observation on safety ...... e patients with haemophilia A.
@nl
type
label
Clinical observation on safety ...... e patients with haemophilia A.
@en
Clinical observation on safety ...... e patients with haemophilia A.
@nl
prefLabel
Clinical observation on safety ...... e patients with haemophilia A.
@en
Clinical observation on safety ...... e patients with haemophilia A.
@nl
P2093
P2860
P921
P1433
P1476
Clinical observation on safety ...... e patients with haemophilia A.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2516.2010.02395.X
P577
2010-09-22T00:00:00Z